How Analysts Rated Mazor Robotics Ltd. (NASDAQ:MZOR) Last Week?

February 19, 2018 - By Stephen Andrade

 How Analysts Rated Mazor Robotics Ltd. (NASDAQ:MZOR) Last Week?

Mazor Robotics Ltd. (NASDAQ:MZOR) Ratings Coverage

Among 7 analysts covering Mazor Robotics (NASDAQ:MZOR), 2 have Buy rating, 2 Sell and 3 Hold. Therefore 29% are positive. Mazor Robotics had 16 analyst reports since November 20, 2015 according to SRatingsIntel. As per Friday, July 8, the company rating was initiated by Standpoint Research. The rating was maintained by Ladenburg with “Buy” on Monday, October 30. The rating was downgraded by Sterne Agee CRT on Tuesday, May 31 to “Neutral”. The firm earned “Hold” rating on Wednesday, August 2 by Needham. The stock of Mazor Robotics Ltd. (NASDAQ:MZOR) earned “Hold” rating by Needham on Thursday, October 5. On Friday, November 20 the stock rating was upgraded by Sterne Agee CRT to “Buy”. The company was downgraded on Wednesday, April 19 by Standpoint Research. The rating was maintained by Needham on Thursday, July 6 with “Hold”. The firm has “Outperform” rating given on Thursday, May 19 by Wells Fargo. The rating was maintained by Needham with “Hold” on Wednesday, August 30. Below is a list of Mazor Robotics Ltd. (NASDAQ:MZOR) latest ratings and price target changes.

30/10/2017 Broker: Ladenburg Rating: Buy New Target: $67.0 Maintain
19/10/2017 Broker: Barclays Capital Rating: Sell New Target: $34.0 Downgrade
09/10/2017 Broker: Barclays Capital Rating: Hold New Target: $34.0
05/10/2017 Broker: Needham Rating: Hold Maintain
30/08/2017 Broker: Needham Rating: Hold Maintain
30/08/2017 Broker: Ladenburg Rating: Buy New Target: $54.0

The stock decreased 2.02% or $1.25 during the last trading session, reaching $60.54. About 512,265 shares traded. Mazor Robotics Ltd. (NASDAQ:MZOR) has risen 206.35% since February 19, 2017 and is uptrending. It has outperformed by 189.65% the S&P500.

Mazor Robotics Ltd., together with its subsidiaries, engages in the development, production, and marketing of medical devices for supporting surgical procedures in the fields of orthopedics and neurosurgery in the United States and internationally. The company has market cap of $1.52 billion. The firm operates in the field of image guided surgery and computer assisted surgery that enable the use of surgical instruments with high precision and minimal invasiveness. It currently has negative earnings. It offers Mazor X surgical guidance system and Renaissance surgical guidance system that transform spine surgery from freehand procedures to guided procedures.

More notable recent Mazor Robotics Ltd. (NASDAQ:MZOR) news were published by: Benzinga.com which released: “Jim Cramer Gives His Opinion On Mazor Robotics And Arista Networks” on December 07, 2017, also Profitconfidential.com with their article: “MZOR Stock: Riding High in The Spine Surgery Market” published on February 13, 2018, Benzinga.com published: “Lightning Round: Jim Cramer Weighs In On Bristol-Myers Squibb, Mazor Robotics …” on October 13, 2017. More interesting news about Mazor Robotics Ltd. (NASDAQ:MZOR) were released by: Livetradingnews.com and their article: “Mazor Robotics Ltd – ADR (NASDAQ:MZOR) Declines 11.88% Pre-Market” published on December 04, 2017 as well as Marketwatch.com‘s news article titled: “Mazor Robotics Ltd. ADR” with publication date: May 19, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.